These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38386842)

  • 1. Correction: YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.
    Minas TZ; Han J; Javaheri T; Hong SH; Schlederer M; Saygideğer-Kont Y; Çelik H; Mueller KM; Temel I; Özdemirli M; Kovar H; Erkizan HV; Toretsky J; Kenner L; Moriggl R; Üren A
    Oncotarget; 2024 Feb; 15():143. PubMed ID: 38386842
    [No Abstract]   [Full Text] [Related]  

  • 2. YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model.
    Minas TZ; Han J; Javaheri T; Hong SH; Schlederer M; Saygideğer-Kont Y; Çelik H; Mueller KM; Temel I; Özdemirli M; Kovar H; Erkizan HV; Toretsky J; Kenner L; Moriggl R; Üren A
    Oncotarget; 2015 Nov; 6(35):37678-94. PubMed ID: 26462019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the oncogenic fusion protein EWS-FLI1 causes G
    Zöllner SK; Selvanathan SP; Graham GT; Commins RMT; Hong SH; Moseley E; Parks S; Haladyna JN; Erkizan HV; Dirksen U; Hogarty MD; Üren A; Toretsky JA
    Sci Signal; 2017 Oct; 10(499):. PubMed ID: 28974650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single enantiomer of YK-4-279 demonstrates specificity in targeting the oncogene EWS-FLI1.
    Barber-Rotenberg JS; Selvanathan SP; Kong Y; Erkizan HV; Snyder TM; Hong SP; Kobs CL; South NL; Summer S; Monroe PJ; Chruszcz M; Dobrev V; Tosso PN; Scher LJ; Minor W; Brown ML; Metallo SJ; Üren A; Toretsky JA
    Oncotarget; 2012 Feb; 3(2):172-82. PubMed ID: 22383402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma.
    Sun W; Rojas Y; Wang H; Yu Y; Wang Y; Chen Z; Rajapakshe K; Xu X; Huang W; Agarwal S; Patel RH; Woodfield S; Zhao Y; Jin J; Zhang H; Major A; Hicks MJ; Shohet JM; Vasudevan SA; Coarfa C; Yang J; Nuchtern JG
    Oncotarget; 2017 Nov; 8(55):94780-94792. PubMed ID: 29212266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1.
    Erkizan HV; Schneider JA; Sajwan K; Graham GT; Griffin B; Chasovskikh S; Youbi SE; Kallarakal A; Chruszcz M; Padmanabhan R; Casey JL; Üren A; Toretsky JA
    Nucleic Acids Res; 2015 Jan; 43(2):1069-80. PubMed ID: 25564528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic modeling optimizes inhibition of the 'undruggable' EWS-FLI1 transcription factor in Ewing Sarcoma.
    Hong SH; Youbi SE; Hong SP; Kallakury B; Monroe P; Erkizan HV; Barber-Rotenberg JS; Houghton P; Üren A; Toretsky JA
    Oncotarget; 2014 Jan; 5(2):338-50. PubMed ID: 24481407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWS-FLI1 induces developmental abnormalities and accelerates sarcoma formation in a transgenic mouse model.
    Lin PP; Pandey MK; Jin F; Xiong S; Deavers M; Parant JM; Lozano G
    Cancer Res; 2008 Nov; 68(21):8968-75. PubMed ID: 18974141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined experience of six independent laboratories attempting to create an Ewing sarcoma mouse model.
    Minas TZ; Surdez D; Javaheri T; Tanaka M; Howarth M; Kang HJ; Han J; Han ZY; Sax B; Kream BE; Hong SH; Çelik H; Tirode F; Tuckermann J; Toretsky JA; Kenner L; Kovar H; Lee S; Sweet-Cordero EA; Nakamura T; Moriggl R; Delattre O; Üren A
    Oncotarget; 2017 May; 8(21):34141-34163. PubMed ID: 27191748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.
    Selvanathan SP; Graham GT; Erkizan HV; Dirksen U; Natarajan TG; Dakic A; Yu S; Liu X; Paulsen MT; Ljungman ME; Wu CH; Lawlor ER; Üren A; Toretsky JA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1307-16. PubMed ID: 25737553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in modeling EWS-FLI1-driven transgenic mouse model for Ewing sarcoma.
    Ramachandran B; Rajkumar T; Gopisetty G
    Am J Transl Res; 2021; 13(11):12181-12194. PubMed ID: 34956445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
    Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
    Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship studies of small molecule disruptors of EWS-FLI1 interactions in Ewing's sarcoma.
    Tosso PN; Kong Y; Scher L; Cummins R; Schneider J; Rahim S; Holman KT; Toretsky J; Wang K; Üren A; Brown ML
    J Med Chem; 2014 Dec; 57(24):10290-303. PubMed ID: 25432018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
    Saulnier O; Guedri-Idjouadiene K; Aynaud MM; Chakraborty A; Bruyr J; Pineau J; O'Grady T; Mirabeau O; Grossetête S; Galvan B; Claes M; Al Oula Hassoun Z; Sadacca B; Laud K; Zaïdi S; Surdez D; Baulande S; Rambout X; Tirode F; Dutertre M; Delattre O; Dequiedt F
    Nucleic Acids Res; 2021 May; 49(9):5038-5056. PubMed ID: 34009296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis.
    Leacock SW; Basse AN; Chandler GL; Kirk AM; Rakheja D; Amatruda JF
    Dis Model Mech; 2012 Jan; 5(1):95-106. PubMed ID: 21979944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells.
    El Beaino M; Liu J; Wasylishen AR; Pourebrahim R; Migut A; Bessellieu BJ; Huang K; Lin PP
    BMC Cancer; 2020 Jan; 20(1):3. PubMed ID: 31898537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPOP and OTUD7A Control EWS-FLI1 Protein Stability to Govern Ewing Sarcoma Growth.
    Su S; Chen J; Jiang Y; Wang Y; Vital T; Zhang J; Laggner C; Nguyen KT; Zhu Z; Prevatte AW; Barker NK; Herring LE; Davis IJ; Liu P
    Adv Sci (Weinh); 2021 Jul; 8(14):e2004846. PubMed ID: 34060252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.
    Sohn EJ; Li H; Reidy K; Beers LF; Christensen BL; Lee SB
    Cancer Res; 2010 Feb; 70(3):1154-63. PubMed ID: 20103643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma.
    Shimizu R; Tanaka M; Tsutsumi S; Aburatani H; Yamazaki Y; Homme M; Kitagawa Y; Nakamura T
    Cancer Sci; 2018 Sep; 109(9):2907-2918. PubMed ID: 29945296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells.
    Bierbaumer L; Katschnig AM; Radic-Sarikas B; Kauer MO; Petro JA; Högler S; Gurnhofer E; Pedot G; Schäfer BW; Schwentner R; Mühlbacher K; Kromp F; Aryee DNT; Kenner L; Uren A; Kovar H
    Oncogenesis; 2021 Jan; 10(1):2. PubMed ID: 33419969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.